| Value & Access Lead |
Dublin (Country President Office (CPO)) |
Irlanda |
International |
Innovative Medicines |
Market Access |
Gen 17, 2025 |
| Senior HEOR Manager |
Dublin (Country President Office (CPO)) |
Irlanda |
International |
Innovative Medicines |
Market Access |
Gen 16, 2025 |
| Value & Access Manager |
Bangkok |
Thailandia |
International |
Innovative Medicines |
Market Access |
Gen 15, 2025 |
| Field Value Access Partner |
Sintra |
Portogallo |
International |
Innovative Medicines |
Market Access |
Gen 15, 2025 |
| AD, Access & Reimbursement RLT Portland, OR - Remote |
Field Non-Sales (USA) |
USA |
US |
Innovative Medicines |
Market Access |
Gen 15, 2025 |
| AD, Access & Reimbursement RLT - Remote - Manhattan/Long Island |
Field Non-Sales (USA) |
USA |
US |
Innovative Medicines |
Market Access |
Gen 15, 2025 |
| Associate Director, Access & Reimbursement RLT - San Diego, CA - Remote |
Field Non-Sales (USA) |
USA |
US |
Innovative Medicines |
Market Access |
Gen 15, 2025 |
| AD, Access & Reimbursement RLT San Francisco, CA - Remote |
Field Non-Sales (USA) |
USA |
US |
Innovative Medicines |
Market Access |
Gen 15, 2025 |
| Bidding Strategy Manager |
Shanghai (Shanghai) |
Cina |
International |
Innovative Medicines |
Market Access |
Gen 15, 2025 |
| Bidding Strategy & Market Access Lead |
Shanghai (Shanghai) |
Cina |
International |
Innovative Medicines |
Market Access |
Gen 15, 2025 |
| Value Regional Access Manager |
Vizcaya |
Spagna |
International |
Innovative Medicines |
Market Access |
Gen 14, 2025 |
| Associate Director, Contracting & Analytics - Remote |
Remote Position (USA) |
USA |
US |
Innovative Medicines |
Market Access |
Gen 13, 2025 |
| Strategic Partnership lead |
Kista |
Svezia |
International |
Innovative Medicines |
Market Access |
Gen 13, 2025 |
| Market Access Specialist |
Mapletree Business City (MBC) |
Singapore |
International |
Innovative Medicines |
Market Access |
Gen 08, 2025 |
| 市场准入经理 |
Fuzhou (Fujian Province) |
Cina |
International |
Innovative Medicines |
Market Access |
Gen 07, 2025 |
| 市场准入大区经理 |
Wuhan (Hubei Province) |
Cina |
International |
Innovative Medicines |
Market Access |
Gen 06, 2025 |
| Sr. HEOR & Access Strategy Manager |
Shanghai (Shanghai) |
Cina |
International |
Innovative Medicines |
Market Access |
Dic 19, 2024 |
| Associate Director, Market Access Early Pipeline & BD&L - Remote |
Remote Position (USA) |
USA |
US |
Innovative Medicines |
Market Access |
Dic 16, 2024 |
| Market Access Lead/Senior Lead |
Toranomon (NPKK Head Office) |
Giappone |
International |
Innovative Medicines |
Market Access |
Dic 15, 2024 |
| HEOR Manager |
London (The Westworks) |
Regno Unito |
International |
Innovative Medicines |
Market Access |
Dic 05, 2024 |
| Director, US HEOR Product Lead - RLT |
Remote Position (USA) |
USA |
US |
Innovative Medicines |
Market Access |
Dic 04, 2024 |
| Senior Public Affairs Manager (m/f/d) |
Berlin West (Non-Sales Force) (Novartis Pharma GmbH) |
Germania |
International |
Innovative Medicines |
Market Access |
Dic 03, 2024 |
| Associate Director RWE Manager |
Dublin (NOCC) |
Irlanda |
Operations |
CTS |
Market Access |
Dic 03, 2024 |
| Innovative Access Partnerships and Engagement Manager |
İstanbul Kavacık |
Turchia |
International |
Innovative Medicines |
Market Access |
Dic 03, 2024 |
| Value Access Manager |
Bogota (Oncology) / Cali (Pharmaceuticals) |
Colombia |
International |
Innovative Medicines |
Market Access |
Dic 03, 2024 |
| Sr. HEOR & Access Strategy Manager |
Beijing (Beijing) |
Cina |
International |
Innovative Medicines |
Market Access |
Nov 29, 2024 |
| Solution & Service Design Manager |
London (The Westworks) |
Regno Unito |
International |
Innovative Medicines |
Market Access |
Ago 15, 2024 |
| Real World Evidence Research Analyst |
Dublin (NOCC) |
Irlanda |
Operations |
CTS |
Market Access |
Ago 12, 2024 |
| Patient Access Lead |
Kyiv |
Ucraina |
International |
Innovative Medicines |
Market Access |
Apr 16, 2024 |
| New Products & Strategic Pricing Partner |
Kyiv |
Ucraina |
International |
Innovative Medicines |
Market Access |
Apr 16, 2024 |